Phospho-NOS2 (Tyr151) Antibody

1. These findings establish a link between iNOS and Notch1 signaling in CD24(+)CD133(+) LCSCs through the activation of TACE/ADAM17. PMID: 30297396
2. This study was the first to demonstrate that KLF5 expression and nitration by iNOS-mediated peroxynitrite are essential for the induction of TNF-alpha and IL-1beta expression in vascular smooth muscle cells (VSMCs) of diabetic vascular tissues. PMID: 28711598
3. iNOS microsatellite polymorphism may contribute to the genetic predisposition to atrial fibrillation in Chinese-Taiwanese patients. PMID: 28205526
4. High expression of iNOS and STAT3 in cells transfected with miR-34a mimic further validated its role. PMID: 30021364
5. These findings support the notion that polymorphic regulation of iNOS expression, altered oxidant-antioxidant components, and evidence of risk association are hallmarks of malaria pathogenesis. iNOS/NO may serve as a potential diagnostic marker in assessing clinical malaria. PMID: 29268202
6. NOS2A_ (CCTTT)n gene variations may influence the susceptibility to inflammatory bowel disease in the Moroccan population. PMID: 29307990
7. The study demonstrated that the expression levels of interleukin-6 and inducible nitric oxide synthase (iNOS) were decreased, while collagen expression and deposition were increased in ketamine-treated smooth muscle cells. Conversely, treatment with CTX restored the expression of iNOS, which may prevent or limit oxidative damage. PMID: 29207018
8. The present study demonstrated that the iNOS C150T polymorphism did not show a significant association with metabolic syndrome. PMID: 29637536
9. KLF4 activated the transcription activity of the iNOS promoter in MH7A cells stimulated by TNF-alpha. This study indicates that KLF4 is important for regulating the expression of iNOS by TNF-alpha in human synoviocytes. PMID: 28744810
10. Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer. PMID: 29087320
11. NOS2 T allele of rs2297514 significantly increased the risk of a non-union during the fracture healing process by 38% compared to the C allele. Further stratification analyses conducted for this SNP using data from subgroups classified by different sites of fracture indicated that significance could only be observed in the tibial diaphysis subgroup. PMID: 29518099
12. NOS2 polymorphisms are being investigated for their potential in predicting the benefit from first-line chemotherapy in metastatic colorectal cancer patients. PMID: 29522543
13. PEDF protects human glomerular mesangial cells from diabetes-derived oxidative stress via NOXO1- iNOS suppression. PMID: 28944893
14. The studies established a potential link between leptin and adipocyte insulin responsiveness in an NOS2-dependent manner. PMID: 28739528
15. Collectively, the results demonstrated that sanggenon C induced apoptosis of colon cancer cells by increasing reactive oxygen species generation and decreasing nitric oxide production, which is associated with inhibition of inducible nitric oxide synthase expression (iNOS) and activation of the mitochondrial apoptosis pathway. PMID: 28849234
16. Data show that infecting unencapsulated E. faecalis cps2 is a stronger stimulator for toll-like receptor 2 (TLR2) and interleukin-1beta (IL-1beta) mRNAs, but not for inducible nitric oxide synthase (iNOS) mRNA. PMID: 28800779
17. Results show that NOS2A CpG(+5099) was associated with increased FeNO and that the magnitude of association between black carbon exposure and demethylation of NOS2A CpG(+5099) measured 5 days later appeared to be greater among seroatopic children, especially those sensitized to cockroach allergens. PMID: 28588744
18. Results support the notion that iNOS polymorphisms are not only associated with Henoch-Schönlein purpura (HSP) risk but also strongly contribute to the genetic basis of individual differences in the progression of HSP to nephritis among Chinese Han children. PMID: 28593405
19. This study investigated whether the -1026(A>C)(rs2779249) and +2087(A>G)(2297518) polymorphisms in the NOS2 gene are associated with chronic periodontitis (CP). The analysis demonstrated, after correction for multiple comparisons, that only the female gender was significantly associated with CP. PMID: 28617311
20. The study summarizes and discusses NOS2 expression in tumor-associated leukocytes and elucidates nitric oxide signaling during tumor initiation and progression. [review] PMID: 27397579
21. Studies show that the majority of patients with gastrointestinal cancer have elevated expression of NOS2. Furthermore, NOS/NO levels are often associated with increased metastasis, leading to poor patient prognosis. The association of elevated NOS2 expression with cancers arising due to bacterial, viral, and fungal infections suggests an important relationship between tumor immune response and chronic inflammation. [review] PMID: 27494631
22. Results show that overexpression of iNOS is associated with an aggressive phenotype and poor survival outcome in ovarian cancer patients, and indicates that iNOS/NO play a dual role in tumor glycolysis and progression. PMID: 28380434
23. Positive rates of iNOS in cervical tissues were 72.1%, 28.2%, and 3.1% in the -HPV-positive patients with cervical cancer (CC group), HR-HPV group, and controls, respectively (P < 0.05). Levels of TLR3, TLR4, TLR7, TLR8, NF-kappaB p65, and iNOS in cervical epithelial cells were higher in the CC group than in other groups. PMID: 28626766
24. Studies show that NOS2 is highly expressed in ovarian and prostate tumors and provide evidence for its role in the development of aggressive ovarian cancer and progression of prostate cancer. [review] PMID: 28326819
25. Studies elucidate the nitric oxide-driven pathways which implicate NOS2 as a key driver of breast cancer disease progression. [review] PMID: 27464521
26. Although haplotype analysis revealed that no NOS2 haplotype was associated with leprosy susceptibility/resistance with statistical significance, the GTG haplotype was noted to be more frequent in healthy controls. PMID: 28315742
27. The results shed light on the potential relevance of NOS2 as a prognostic factor for glioma malignancy and recurrence. PMID: 28424427
28. These data revealed that human endogenous retrovirus W env might contribute to increasing nitric oxide production and microglial migration ability in neuropsychological disorders by regulating the expression of inducible nitric oxide synthase. PMID: 28656540
29. Since RP11-19P22.6-001 acts in cis to regulate nitric oxide synthase 2 (NOS2), we also analyzed NOS2 expression and its correlation with gastric cancer. The combined use of lncRNAs and their target genes may be a promising method to increase the diagnostic value of lncRNAs in cancer. PMID: 28128738
30. expression elevated in preeclampsia placentas PMID: 27030287
31. Inducible nitric oxide synthase is able to regulate many cytokines in mast cells involved in the development of irritable bowel syndrome. PMID: 26940641
32. Role of a conserved tyrosine residue in the FMN-Heme interdomain electron transfer in inducible nitric oxide synthase. PMID: 27633182
33. expression highly associated with hallmarks of psoriasis such as hypogranulosis and neutrophils, but negatively associated with eosinophils and spongiosis which are characteristics of eczema PMID: 27193975
34. Bone marrow mesenchymal stromal cells induce the rapid differentiation of CD11b+ myeloid cells from bone marrow progenitors, and such an activity requires the expression of nitric oxide synthase-2. PMID: 28183849
35. Studied iNOS (inducible nitric oxide synthase) activation through mPGES-1 (microsomal prostaglandin E synthase-1) signaling driven by EGFR (EGF receptor) in cancer progression models. PMID: 28257996
36. Higher expression of inducible nitric oxide synthase (NOS2) is associated with poor survival in patients with pancreatic ductal adenocarcinoma (PDAC). PMID: 27367029
37. The Oncogenic Properties Of The Redox Inflammatory Protein Inducible Nitric Oxide Synthase In ER(-) Breast Cancer. PMID: 28162269
38. Exploration into the mechanisms of the cGMP-mediated protection identified a role for the iNOS/NO/cGMP pathway in the activation of ADAM17 (TACE), which is a sheddase that cleaves a number of cell surface receptors including TNF receptor type 1 (TNFR1). PMID: 28162283
39. results suggest that NOS2 polymorphisms may influence the risk of aggressive prostate cancer and that these polymorphisms could have an impact on disease pathogenesis, possibly by affecting intracellular nitric oxide levels. PMID: 28162285
40. No significant difference in frequency of the NOS2-1659C/T polymorphism was observed between patients and controls. None of the studied SNPs were associated with erosive disease, seropositivity, or extra-articular manifestations. The -277A/G and -1026 G/T promoter polymorphisms in iNOS may confer susceptibility to rheumatoid arthritis (RA) in South Indian Tamils. PMID: 28374504
41. This is the first reported evidence for NO-enhanced bystander aggressiveness in the context of PDT. In the clinical setting, such effects could be averted through pharmacologic use of iNOS inhibitors as non-ionizing photodynamic therapy adjuvants. PMID: 27884704
42. This increase was inhibited in the presence of the nonspecific iNOS inhibitor aminoguanidine (AG). PMID: 27247425
43. Our study shows that the expression of iNOS is increased in both central airways and the alveolar parenchyma, but not in BAL cells, in uncontrolled asthmatics compared to controlled asthmatics and healthy controls. PMID: 27647044
44. We found that lowering the glucose concentration increased expression of genes coding for inducible nitric oxide syntheas, NOS2 and NOS2A, resulting in enhanced production of nitric oxide. PMID: 28157664
45. Downregulation of inducible NO synthetase (iNOS) resulted in downregulation of heme oxygenase 1 (HO-1), and, conversely, upregulation of iNOS enhanced HO-1 activity. PMID: 27752990
46. expression in synovial subintima was significantly higher in early than in advanced osteoarthritis. PMID: 27958655
47. ATM-reactive oxygen species-iNOS axis regulates nitric oxide mediated cellular senescence. PMID: 27845209
48. The risk of developing chronic pancreatitis is not increased by the presence of the iNOS-2087A>G polymorphism. PMID: 28125406
49. NOS2 rs2779248, NOS2 rs1137933, and NOS3 rs3918188 genetic polymorphisms are potentially related to the susceptibility to type 2 diabetes mellitus (T2DM), and the rs1800783 polymorphism might be considered as a genetic risk factor for diabetic nephropathy. PMID: 27192959
50. Patients with Marfan syndrome showed elevated NOS2 and decreased ADAMTS1 protein levels in the aorta. PMID: 28067899

Show More

Hide All

HGNC: 7873

OMIM: 163730

KEGG: hsa:4843

STRING: 9606.ENSP00000327251

UniGene: Hs.709191